Status:
RECRUITING
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
Lead Sponsor:
Washington University School of Medicine
Conditions:
Breast Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
The main purpose of this study is to compare genetic markers present on tumor cells before and after chemotherapy.
Detailed Description
In this study, the investigators propose that persistent disseminated tumor cells (DTC) present after systemic therapy represent a unique subpopulation of all DTC, are predictors of a poor response to...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Recently diagnosed with clinical stage II, III, or IV breast cancer
- Planning to undergo neoadjuvant or adjuvant systemic therapy; patients who have already completed neoadjuvant systemic therapy are also eligible
- Must be \>= 18 years of age
- If female, must not be pregnant
- Must not have Hepatitis B, C, or HIV
- Must be willing and able to sign informed consent document
Exclusion
Key Trial Info
Start Date :
September 14 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00353483
Start Date
September 14 2005
End Date
August 31 2026
Last Update
November 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63119